Immunomedics (IMMU) – Momentum Movers
-
Immunomedics (IMMU) Climbs 155% After Resuming Trading
-
Immunomedics (IMMU) Updated Results With Sacituzumab Govitecan In Patients With Relapsed Or Refractory mTNBC
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to IMMU Stock Lookup